• Ross Arena, Jonathan Myers, Joshua Abella, Sherry Pinkstaff, Peter Brubaker, Brian Moore, Dalane Kitzman, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Daniel Forman, Erin West, and Marco Guazzi.
• Department of Physical Therapy, Virginia Commonwealth University, Richmond, Virginia, USA. Raarena@vcu.edu
• Am. J. Cardiol. 2009 Oct 15;104(8):1116-21.

AbstractSeveral investigations have demonstrated that higher body weight, as assessed by the body mass index, is associated with improved prognosis in patients with heart failure (HF). The purpose of the present investigation was to assess the influence of HF etiology on the prognostic ability of the body mass index in a cohort undergoing cardiopulmonary exercise testing. A total of 1,160 subjects were included in the analysis. All subjects underwent cardiopulmonary exercise testing, at which the minute ventilation/carbon dioxide production slope and peak oxygen consumption were determined. In the overall group, 193 cardiac deaths occurred during a mean follow-up of 30.7 +/- 25.6 months (annual event rate 6.0%). The subjects classified as obese consistently had improved survival compared to those classified as normal weight (overall survival rate 88.0% vs or=43.4, p <0.001) for both etiologies, and the body mass index added prognostic value (residual chi-square >or=4.7, p <0.05). In conclusion, these results further support the notion that obesity confers improved prognosis in patients with HF, irrespective of the HF etiology. Moreover, the body mass index appears to add predictive value during the cardiopulmonary exercise testing assessment. However, survival appears to differ according to HF etiology in subjects classified as overweight.

27 keywords...

hide…